Research from Chang Gung Memorial Hospital Yields New Data on Type 2 Diabetes (Hypoglycemia Associated With Drug-Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors)

摘要

2021 MAY 03 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Fresh data on type 2 diabetes are presented in a new report. According to news reporting out of the Chang Gung Memorial Hospital by NewsRx editors, research stated, "Dipeptidylpeptidase-4 inhibitors (DPP-4i's) are considered to be safe for patients with type 2 diabetes mellitus (T2DM). However, little is known about drug-drug interactions between DPP-4i's and concurrent medications." Our news reporters obtained a quote from the research from Chang Gung Memorial Hospital: "Data on patients using DPP-4i's for T2DM during 2011-2017 were retrieved from Chang Gung Research database provided by Chang Gung Memorial Hospital. Patients were excluded if they were aged 90 years; had incomplete demographic data; had insulinoma; or had records of concomitant insulin use. A generalized estimating equation-based Poisson model was employed for statistical analysis. The primary outcome was hypoglycemia events. We retrieved data on a total of 97,227 patients using DPP-4i's.